Tricida

Tricida is a California-based pharmaceutical company that develops and commercializes investigational drugs for the treatment of chronic kidney disease.

Business Model:

Revenue: $0

Employees: 51-200

Detailed Tricida Information

Geographic Data

Tricida headquarters map

Address: 7000 Shoreline Court

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$42M

Raised Total:

$499M

Metrics

3,879,269Website Global Rank

3,195Website Monthly Traffic

Twitter Followers

Description

Tricida is a California-based pharmaceutical company that develops and commercializes investigational drugs for the treatment of chronic kidney disease.

Contact Phone:
+14154297800

Contact Email:

Tricida went public on 6/27/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/27/2018

IPO Valuation:
$763M

Ticker Symbol:
TCDA

IPO Price:
$19/share

Amount Raised:
$222M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
5/2020 Post-IPO Debt $200M
7/2016 Series C $0 Longitude Capital
Vivo Capital
Limulus Venture Partners
OrbiMed
Sibling Capital
Longitude Capital
Vivo Capital
Limulus Venture Partners
OrbiMed
Sibling Capital
3/2018 Debt Financing 1 $100M Hercules Capital
Hercules Capital
Hercules Capital
Hercules Capital
11/2021 Post-IPO Equity 3 $42M Deep Track Capital
Frazier Healthcare Partners
OrbiMed
Deep Track Capital
Frazier Healthcare Partners
OrbiMed
11/2017 Series D $0 Longitude Capital
OrbiMed
Vivo Capital
Sibling Capital
Venrock
Cormorant Asset Management
Limulus Venture Partners
Wellington Management
Longitude Capital
OrbiMed
Vivo Capital
Sibling Capital
Venrock
Cormorant Asset Management
Limulus Venture Partners
Wellington Management
3/2015 Series B $0 OrbiMed
Limulus Venture Partners
Sibling Capital
OrbiMed
Limulus Venture Partners
Sibling Capital
9/2014 Series A $0 OrbiMed
Limulus Venture Partners
Sibling Capital
OrbiMed
Limulus Venture Partners
Sibling Capital
1/2014 Venture Round $4.5M
10/2022 Post-IPO Debt $125M Hercules Capital, Inc
10/2022 Post-IPO Debt $125M Hercules Capital
Hercules Capital
5/2020 Post-IPO Debt $175M
6/2018 IPO $222.3M
11/2017 Series D 8 $57.5M Longitude Capital
OrbiMed
Vivo Capital
Sibling Capital
Venrock
Cormorant Asset Management
Longitude Capital
OrbiMed
Vivo Capital
Sibling Capital
Venrock
Cormorant Asset Management
7/2016 Series C 5 $55M Longitude Capital
Vivo Capital
Longitude Capital
Vivo Capital
3/2015 Series B 3 $30M OrbiMed
OrbiMed
9/2014 Series A 3 $10M OrbiMed
OrbiMed
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research